Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancerZhuokai Zhuang, Yanxin Luo, Peiyi Xie et al.|Journal of Translational Medicine|2021Cited by 23
Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC studyJianwei Zhang, Yanhong Deng, Yue Cai et al.|Oncotarget|2015Cited by 14